Why Teva Pharmaceutical Industries Fell Today
The pharmaceutical giant whiffs on both the top and bottom lines in its Q3.
Why Avid Bioservices Stock Surged 14% Today
The stock will be part of a well-known index.
Why Esperion Therapeutics Plummeted by 11% Today
Shareholders were displeased with the company's latest financial move.
Why Novavax Fell by 3% Today
Good news for a rival's coronavirus vaccine compounds worries about the company's shot.
Why GoHealth Is Blasting Higher This Week
We've just entered a busy and, hopefully for investors, lucrative period for the health insurance marketplace operator.
Why iQiyi Stock Was Winning This Week
Investors are taking that old adage "content is king" to heart with the productive video-streaming company.
Why Shares of Healthcare Services Group Dived by 14% Today
Its Q3 profitability fell notably short of expectations.
Why Abbott Laboratories Shot Higher Today
All four of the company's divisions posted strong growth, but one in particular was a standout.
3 Dividend Raises You Can Still Take Advantage of
Three big names in the stock market are paying more for investors to own their stock.
Why Nikola Stock Popped by Nearly 5% Today
The company's legal action against Tesla will go forward after all.
Why Johnson & Johnson Shares Trounced the Market Today
The healthcare giant recorded healthy growth in all three of its business segments and raised its guidance.
Why Medtronic Fell by Almost 6% on Monday
An important clinical trial will last longer than some expected.
Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
An analyst initiated coverage of the biotech stock with a unambiguous buy recommendation.
10,126 Reasons for WWE Investors to Worry Right Now
A determined rival has been having a lot of success lately.
Why Shares of XP Soared on Friday
An analyst upgrades his recommendation on the stock to the equivalent of a buy.
Why Corsair Gaming Tumbled by 8% Today
Two analysts have become less optimistic on the stock.
Why Moderna Stock Trounced the Market Today
The company's coronavirus vaccine booster shot received a major boost from an FDA panel of experts.
Why HubSpot Beat the Market on Wednesday
Several analysts raised their price targets on the stock, at times, significantly.
Why Sarepta Therapeutics Tumbled Today
Investors weren't wowed by a company update, or by news of a fresh stock issue.
Why Charlotte's Web Had a Seesaw Tuesday
Investors were mulling the effect of a new sticker that will appear on the company's products.